Momenta Pharmaceuticals, Inc. (MNTA)

[alternatepatel]

Partnership or Buyout?

I believe buyout have low probabilities as it becomes increasingly difficult to derive a valuation agreeable to both the acquirer and $MNTA.

Reg. M923 from latest CC:

"Now that we have full ownership of this late-stage program, we are evaluating our options for potentially capturing significantly more value from this program. As we stated in the past, we've had inquiries from interested parties and are now in active discussions with multiple potential collaboration partners and evaluating different opportunities to maximize the value of this asset. As you know, deals take some time to negotiate and we will update you as soon as we have news that we can communicate."

The patent invalidation news can speed up the process.